Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_839f1312b3f147a61773b6bedce79cea http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5be2d9abe0506424930d52483af65e67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cac023d2e2874224ecbbcccbdea1fc91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a58ac12014da3119fe88390f8a15322d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
filingDate |
2009-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af626ff0845accdabea24bb5e662622c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77bb025b9beecee44a4b9b636cc6278e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11824b48b708eccdaa6f600f430a73fb |
publicationDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009099174-A1 |
titleOfInvention |
Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient |
abstract |
Provided is a novel therapeutic agent or preventive agent for an inflammatory bowel disease. The therapeutic agent or preventive agent for an inflammatory bowel disease comprises an amino alcohol derivative which is a sphingosine-1-phosphate receptor agonist and represented by formula (1), a pharmacologically acceptable salt thereof or a hydrate thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014523887-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015194157-A1 |
priorityDate |
2008-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |